Acadia Pharmaceuticals buy BMO Capital Markets
Start price
27.06.24
/
50%
€15.27
Target price
27.06.25
€28.91
Performance (%)
0.16%
Price
27.06.24
€15.30
Summary
This prediction is currently active. Since the start of the prediction for Acadia Pharmaceuticals the price has only changed by 0.16%. This prediction currently runs until 27.06.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Acadia Pharmaceuticals | 0.16% |
iShares Core DAX® | 0.238% |
iShares Nasdaq 100 | -0.304% |
iShares Nikkei 225® | 2.271% |
iShares S&P 500 | -0.296% |
Comments by BMO_Capital_Markets for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $31.00 price target on the stock.
Ratings data for ACAD provided by MarketBeat